Prophase Labs, INC. (PRPH) — 10-Q Filings

10-Q Filings (6)

• ProPhase Labs' Revenue Plummets Amid Diagnostic Business Exit — Nov 19, 2025 Risk: high
  ProPhase Labs, Inc. (PRPH) reported a net loss of $6.839 million for the three months ended September 30, 2025, compared to a net loss of $6.587 million in the
• ProPhase Labs Narrows Loss to $0.51M Amid Strategic Divestiture — Aug 13, 2025 Risk: high
  ProPhase Labs, Inc. (PRPH) reported a net loss of $0.51 million for the six months ended June 30, 2025, a significant improvement from the $12.42 million net lo
• ProPhase Labs Files Q1 2025 10-Q — May 20, 2025 Risk: low
  ProPhase Labs, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter
• ProPhase Labs Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  ProPhase Labs, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nine mon
• ProPhase Labs Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  ProPhase Labs, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as QUIGLEY CORP, reported its financial status. Key financia
• ProPhase Labs, Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
  ProPhase Labs, Inc. (PRPH) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. ProPhase Labs, Inc. filed a 10-Q report for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX